neubond

Neubond specialises in personalised home rehabilitation devices for stroke patients to address their mobility constraints. Our innovative devices establish a direct connection to the patient’s body, seamlessly integrating effective therapy into their daily lives.

https://neubond.co.uk/

2-10 employees

Growth Trajectory

Neubond's growth potential lies in expanding its user base through clinical trials and exclusive offers, leveraging its scientific validation and partnerships with institutions like Imperial College London. Further growth can be achieved through active engagement on social media platforms and eventual development of 'Terms and Conditions' and 'Website Disclaimer' pages to establish credibility.

Technical Challenges

Tech Stack

Team Size

CEO

CTO

Scientific Advisor

Clinical Advisor

Operational Advisor

Commercial Advisor

Key Risks

Dependence on scientific validation may limit flexibility in adapting to market demands.

Lack of fully developed legal pages ('Terms and Conditions', 'Website Disclaimer') could raise trust concerns.

Potential challenges in scaling personalized therapy solutions to a larger user base.

Competition from established rehabilitation centers and alternative therapy methods.

Opportunities

Leveraging scientific partnerships (Imperial College London) for credibility and further innovation.

Expanding the range of rehabilitation solutions beyond the current offering.

Developing strong relationships with healthcare providers for referrals and partnerships.

Building a robust online community to foster social connection among users.

Live Data Stream

Access Our Live VC Funding Database

30,000+ funded startups

tracked in the last 3 months

B2B verified emails

of key decision makers

Growth metrics

Real-time company performance data

Live updates

of new VC funding rounds

Advanced filters

for sophisticated queries

API access

with multiple export formats

Access Database

Updated every 5 minutes